CC
Casdin Capital Portfolio holdings
AUM
$1.1B
1-Year Return
24.98%
This Quarter Return
+2.75%
1 Year Return
+24.98%
3 Year Return
+152.8%
5 Year Return
+110.01%
10 Year Return
–
AUM
$1.21B
AUM Growth
-$70.2M
(-5.5%)
Cap. Flow
-$36.8M
Cap. Flow
% of AUM
-3.04%
Top 10 Holdings %
Top 10 Hldgs %
64.66%
Holding
46
New
2
Increased
11
Reduced
10
Closed
6
Top Buys
| 1 |
Relay Therapeutics
RLAY
|
+$43.9M |
| 2 |
Intellia Therapeutics
NTLA
|
+$36.5M |
| 3 |
GeneDx Holdings
WGS
|
+$31.3M |
| 4 |
Structure Therapeutics
GPCR
|
+$16.1M |
| 5 |
4D Molecular Therapeutics
FDMT
|
+$7.56M |
Top Sells
| 1 |
BPMC
Blueprint Medicines
BPMC
|
+$36.3M |
| 2 |
Illumina
ILMN
|
+$25.6M |
| 3 |
MaxCyte
MXCT
|
+$22.7M |
| 4 |
Sarepta Therapeutics
SRPT
|
+$21.4M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
+$19M |
Sector Composition
| 1 | Healthcare | 99.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Fate Therapeutics
FATE
$113M
| $11.7M | 0.96% |
2,050,000
| – | – |
|
27
Century Therapeutics
IPSC
$43.4M
| $11.1M | 0.92% |
3,206,380
| – | – |
|
28
Twist Bioscience
TWST
$1.51B
| $10.6M | 0.87% |
700,000
-245,000
| -26% | -$3.69M |
|
29
Absci
ABSI
$380M
| $9.44M | 0.78% |
5,393,260
-1,970,000
| -27% | -$3.45M |
|
30
Prime Medicine
PRME
$734M
| $9.03M | 0.74% |
734,350
| – | – |
|
|
DICE
31
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $8.88M | 0.73% |
310,000
+145,000
| +88% | +$4.15M |
|
32
OptimizeRx
OPRX
$330M
| $7.32M | 0.6% |
500,000
+240,000
| +92% | +$3.51M |
|
33
Incyte
INCY
$16.7B
| $5.6M | 0.46% |
77,500
| – | – |
|
34
Monte Rosa Therapeutics
GLUE
$298M
| $3.98M | 0.33% |
510,882
| – | – |
|
35
Tango Therapeutics
TNGX
$759M
| $3.95M | 0.33% |
+1,000,000
| New | +$3.95M |
|
|
OMIC
36
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| $1.63M | 0.13% |
44,857
| – | – |
|
|
NVTA
37
DELISTED
Invitae Corporation
NVTA
| $1.4M | 0.12% |
1,038,388
-8,000,000
| -89% | -$10.8M |
|
|
EXAI
38
DELISTED
Exscientia Plc American Depositary Shares
EXAI
| $1.13M | 0.09% |
213,900
| – | – |
|
|
LIAN
39
DELISTED
LianBio American Depositary Shares
LIAN
| $403K | 0.03% |
206,415
| – | – |
|
|
KRON
40
DELISTED
Kronos Bio
KRON
| $181K | 0.01% |
123,839
| – | – |
|
41
Arvinas
ARVN
$587M
| – | – |
-200,000
| Closed | -$6.84M |
|
42
Definitive Healthcare
DH
$431M
| – | – |
-360,000
| Closed | -$3.96M |
|
43
Keros Therapeutics
KROS
$638M
| – | – |
-65,000
| Closed | -$3.12M |
|
44
Moderna
MRNA
$9.52B
| – | – |
-60,000
| Closed | -$10.8M |
|
45
Veeva Systems
VEEV
$46.3B
| – | – |
-50,000
| Closed | -$8.07M |
|
46
Wave Life Sciences
WVE
$1.19B
| – | – |
-200,000
| Closed | -$1.4M |
|